Capivasertib Impurity 21 | CAS 68208-26-4 - Request Quote
Capivasertib Impurity 21
| SZ CAT No: | SZ-C254030 |
| CAS No | 68208-26-4 |
| Mol.F. | C9H12ClNO |
| Mol.Wt. | 185.7 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Capivasertib Impurity 21 is chemically 3-Amino-3-(4-chlorophenyl)propan-1-ol. Capivasertib Impurity 21 is supplied with detailed characterization data compliant with regulatory guideline. Capivasertib Impurity 21 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Capivasertib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 68208-26-4
Purchase 68208-26-4
Order 68208-26-4
Enquire 68208-26-4
price of 68208-26-4
68208-26-4 Supplier
68208-26-4 Manufacturer
68208-26-4 Exporter
buy high quality Capivasertib Impurity 21
Purchase Capivasertib Impurity 21
Capivasertib Impurity 21 suppliers
Capivasertib Impurity 21 manufacturers
Capivasertib Impurity 21 price
Order Capivasertib Impurity 21
Enquire Capivasertib Impurity 21
Capivasertib Impurity 21 cost
Capivasertib Impurity 21 Supplier
Capivasertib Impurity 21 Distributor
Capivasertib Impurity 21 for Method Validation
Capivasertib Reference Standard
Capivasertib Impurity 21 for ANDA Filing
Capivasertib Impurity 21 for Forced Degradation Studies
Capivasertib Impurity 21 Identification Standards
Capivasertib Impurity 21 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


